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Preparation of dipyrrins from F-BODIPYs by treatment with 
methanesulfonic acids†  
J. Urieta,
a
 B. L. Maroto,
a
 F. Moreno,
a
 A. R. Agarrabeitia,
a
 M. J. Ortiz
a
 and S. de la Moya
a,* 
An alternative metal-free soft procedure for the preparation of dipyrrins from F-BODIPYs is reported. The new method 
makes possible to obtain certain dipyrrin derivatives that were unaccessible from F-BODIPYs to date. To demonstrate the 
ability of the new procedure, dipyrrins having highly reactive groups, such as chloro, cyano or acetoxyl, have been easily 
obtained from the corresponding F-BODIPY, which shows the synthetic utility of the reported methodology.  
Introduction 
Difluoroboron-dipyrromethene (F-BODIPY) complexes (see 1 in 
Figure 1) are widely known as valuable organic dyes for the 
development of useful photonic tools, such as fluorescent 
chemical sensors and probes, fluorescent security labels, dye-
lasing systems, dyes for bioimaging, light harvesting materials, 
energy-converting antenna systems, or photodynamic therapy 
agents, among other interesting photonic applications.
1 
 
Beyond photonics, F-BODIPYs can be also employed as 
synthetic precursors in the preparation of dipyrrins (see 2 in 
Figure 1),
2
 which are important molecules in medicinal 
chemistry and materials science (e.g., as synthetic 
intermediates for biologically active porphyrinoids, or for the 
design of specific cation- or anion-binding supramolecular 
systems).
3
 The importance of this synthetic use of F-BODIPYs is 
due to their higher chemical stability when compared to the 
corresponding dipyrrins, making possible chemical 
transformations on the BODIPY core which are impracticable 
on the dipyrrin.
2a,b
 In other words, the F-BODIPY difluoroboron 
(BF2) group is a very convenient protecting/activating group to 
take into account when projecting the synthesis of a 
functionalized dipyrrin. Moreover, the so-obtained dipyrrins 
can be also used for preparing other BODIPYs (e.g., certain C-
BODIPYs which cannot be synthesized directly from the 
corresponding parent F-BODIPYs by simple fluorine 
substitution).
4 
However, the known stability of F-BODIPYs, 
joined to the also known high instability of dipyrrins,
3a
 makes 
the decomplexation of F-BODIPYs a non-trivial process, 
especially when highly reactive dipyrrins are required. 
 Up to now, two main procedures are available for 
decomplexing F-BODIPYs (see Figure 1): The useful “basic” 
method developed by Thompson and co-workers,
2a,b
 which 
involves strong basic conditions (e.g., potassium hydroxide or 
tert-butoxide in tert-BuOH under microwave, MW, irradiation), 
and the “Lewis-acid” method, developed first by Ravinkanth 
and co-workers (e.g., ZrCl4 or TiCl4 in refluxing MeCN/MeOH),
2e
 
further improved by the Thompson group under softer 
conditions (e.g., BF3 or BCl3 in CH2Cl2 at room temperature, 
r.t.).
2f 
 
Figure 1. Dipyrrins by BF2 removal in BODIPYs. Established procedures. 
 However, the scope of these procedures is not general: the 
Ravinkanth method seems to be efficient only for 8-aryl-F-
BODIPYs;
2e
 the basic Thompson procedure cannot be applied 
to F-BODIPYs having functional groups labile under the 
required strong basic conditions (e.g., halogen at the C3/5 
BODIPY positions,
2d
 or easily enolizable functionalities
2b
); the 
softer (r.t.) Lewis-acid Thompson procedure requires electron-
rich enough F-BODIPYs (e.g., polyalkylated F-BODIPYs).
2f
 
Moreover, metal cations are involved in all these procedures, 
and this can be a limitation when obtaining highly chelating 
dipyrrins. These drawbacks make necessary the establishment 
of an alternative wide-scope method for the preparation of 
dipyrrins from F-BODIPYs, taking place under soft enough 
reaction conditions and free of metal cations, as well. Herein, 
we report such a method, in which methanesulfonic acid or 
trifluoromethanesulfonic acid in methylene dichloride 
promotes the desired F-BODIPY decomplexation. 
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Results and discussion 
Within the frame of our research work in the chemistry of 
BODIPYs,
5
 we found that methanesulfonic acid was able to 
remove the BF2 group in electron-poor F-BODIPYs under very 
soft conditions (methylene dichloride at r.t.), despite the 
known stability of this kind of BODIPYs (electron poor) toward 
strong acids (e.g., trichloroacetic or trifluoroacetic acid) 
reported before.
6
 Oppositely to this statement, the electron-
rich polyalkylated 1,3,5,7,8-pentamethyl-2,6-diethyl-F-BODIPY 
has been demonstrated to be unstable in the presence of di- 
or trichloroacetic acid.
7
 Related to the latter result, Yu et al. 
have recently reported BF2 removal in certain 1,3,5,7-
tetramethyl-8-aryl-F-BODIPYs by using trifluoroacetic acid or 
HCl in aqueous organic solvents,
8 
as it was also observed by 
Liras et al. in F-BODIPYs substituted with amino or amido 
groups.
9
 However, these procedures are expected to fail for F-
BODIPYs with higher electron-poor character (F-BODIPY 
protonation must be involved in the decomplexation 
activation, see later), and they have been shown incompatible 
with certain hydrolyzable functionalities (e.g., acetamide).
9 
 To prove the ability of methanesulfonic acids to activate 
the BF2 removal in F-BODIPYs under soft conditions, we came 
interested in testing a difficult case: the decomplexation of 
dichlorinated 8-aryl-F-BODIPY 3
10
 (Figure 2). Although the 
corresponding dichlorinated dipyrrin can be easily obtained by 
well-established methods from pyrrole derivatives,
10 
we chose 
the study of this case for three main reasons: (1) the high 
electron-poor character of 3, that should make it highly inert 
toward standard Lewis acid conditions; (2) the known SNAr 
reactivity of 3 toward nucleophiles (chlorine substitution), due 
to the said electron-poor character; (3) the known instability of 
the corresponding dichlorinated dipyrrin. 
 
Figure 2. BF2 removal in 3 (final water treatment was conducted in all cases). 
 Indeed, trying to remove the BF2 group in 3 by the basic 
Thompson procedure affords decomposition (Figure 2). This 
result was expected, due to the presence of chlorine atoms at 
the C3/5 positions of the starting F-BODIPY. These chlorine 
atoms must easily undergo SNAr under the used strong basic 
reaction conditions.
2d,10
 Besides, said chlorines would make 
the final dipyrrin highly reactive and therefore, unstable under 
the severe conditions employed for the removal. 
 On the other hand, 3 was recovered in 60% yield (isolated 
yield after chromatographic purification) when performing the 
softer Lewis-acid (BCl3) Thompson procedure (Figure 2). It 
must be noted here that the desired final dipyrrin was not 
detected by 
1
H-NMR analysis of the crude mixture prior 
purification. The observed result is explained on the basis of 
the electron-poor character of 3 (note the strong electron-
withdrawing inductive effect (-I) exerted by the chlorine 
atoms), which should diminish the Lewis basicity of its nitrogen 
centers.
2f
 
 Trying to remove the BF2 group of 3 by treatment with 
methanesulfonic acid was also unsuccessful. Thus, 3 does not 
react with this acid in CH2Cl2 solution, even under refluxing 
conditions (40 ºC for 24 h; see Figure 2). However, using the 
stronger trifluoromethanesulfonic acid, TfOH, at r.t. gave fairly 
place to the desired dichlorinated dipyrrin as the 
corresponding salt 4 in ca. quantitative yield (see Figure 2). 
 The latter result clearly shows that the BF2 removal is 
activated by the protonation of the F-BODIPY core (1), which 
requires a strong enough Brönsted acid due to its weak-base 
character (Figure 3). After final hydrolysis (nucleophilic water 
attack to the electrophylic boron in the formed intermediate), 
the so-obtained free dipyrrin (2) would be protonated by a 
second mol equiv. of the strong acid present in the reaction 
medium, to generate the corresponding dipyrrin salt (isolated 
final product), whereas the formed BF2OH would react with 
additional water molecules to generate B(OH)3.
11 
 
Figure 3. Activation of F-BODIPY decomplexation by protonation. 
 Encouraged by the result obtained by 3, we decided to 
carry out a screening of BF2 removal from a set of differently 
substituted F-BODIPYs using methanesulfonic and 
trifluoromethanesulfonic acids (Table 1). We observed that, in 
agreement with the proposed way of activation (i.e., involving 
an initial protonation), the use of a softer acid 
(methanesulfonic) led to the corresponding dipyrrin salt 
starting from alkyl F-BODIPYs 5a-d (see Table 1), due to the 
expected higher basic character of the involved F-BODIPY core 
when compared to 3. (Note the expected different effect of 
the electron-withdrawing chlorines vs. the electron-donor 
alkyls on the basicity of the F-BODIPY core). The dipyrrins were 
obtained as the corresponding stable methanesulfonic acid 
salt.  
 To check the expected presence of a single unit of organic 
acid in the structure of the obtained dipyrrin salts, the amount 
of fluorine in salt 6b (involving strong-acid and -base partners) 
was determined by 
19
F-NMR (p-trifluoromethylacetophenone 
N
B
N
FF
3
Cl Cl
3 (100%)
N HN
4
Cl Cl
(ca. 100%)
Decomposition
MeSO3H
CH2Cl2 / 40 ºC
TfOH
CH2Cl2 / r.t.
t-BuOH / MW
t-BuOK
TfOH
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BF2
H
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was used as internal standard; see ESI†), showing a single unit 
of TfOH in its structure. 
 Also in agreement with the mechanism shown in Figure 3, 
it was possible to remove the BF2 group in the presence of 
water. Thus, 5b was converted to the corresponding dipyrrin 
salt by treatment with TfOH in aqueous CH2Cl2 (Method C) 
instead of dry CH2Cl2 (Method B). However, using water as the 
only solvent (Method D) noticeably reduces the effectiveness 
of the process, probably due to the insolubility of both the 
starting BODIPY and the final dipyrrin salt in water (see Table 
1). 
Table 1. BF2 removal in selected F-BODIPYs promoted by methanesulfonic acids. 
BODIPY R
1
 R
2
 R
3
 R Met.
a
 Dipyrrin salt 
(yield) 
5a Me Me H Me A 6a (92%) 
5b Me Me Et Me A 6b (99%) 
CF3 B 6b’ (98%) 
CF3 C 6b’ (98%) 
CF3 D 6b’ (trace) 
5c Nonyl Me tBu Me A 6c (97%) 
5d Me Me Bu Me A 6d (100%) 
5e CH2OAc Me Et Me A No reaction 
CF3 B 6e/7
b 
(99%) 
CF3 C Complex mixt. 
5f CN Me Et Me A No reaction 
CF3 B 6f (98%) 
5g Mesityl H H CF3 B 6g (98%) 
a
 Method A: Methanesulfonic acid in refluxing CH2Cl2 overnight; Method B: TfOH 
in CH2Cl2 at r.t. overnight; Method C: TfOH in aqueous CH2Cl2 at r.t. overnight; 
Method D: TfOH in water at r.t. overnight. 
b
 7 is the corresponding hydroxylated 
dipyrrin salt coming from the ester hydrolysis (6e/7 = 5/6 determined by 
1
H 
NMR). 
 Noticeably, the essayed decomplexations of meso-alkyl-F-
BODIPYs took place without detecting dypyrrin 
tautomerization to the corresponding 1,1-di-1H-pyrrol-2-
ylethene derivative (Figure 4), despite the known 
tautomerizable character of the involved meso alkyl groups.
12
 
In regard to this, it is known that the decomplexation of 5b 
under basic conditions affords the corresponding 1,1-
dipyrrolylethene instead of the dipyrrin.
2b 
 Interestingly, the sulfonic acid-promoted decomplexation 
took place without tautomerization even for acetoxylated 5e 
(see Table 1), despite the higher reactivity towards 
tautomerization expected for its meso methylene group. 
However, TfOH instead of methanesulfonic acid was required 
to remove the BF2 group in this case, probably due to the 
electron-withdrawing effect exerted by the acetoxyl group, 
which lowers the key BODIPY basicity. For the same reasons, 
the decomplexation of electronically deactivated (electron-
poor) 5f required the use of TfOH, as well (see Table 1). 
 
Figure 4. Dipyrrin - 1,1-di-1H-pyrrol-2-ylethene tautomerization in meso-
methyldipyrrins. 
 It is worth to mention that, despite the highly hydrolyzable 
character of the acetoxyl group of 5e, ca. 45% mol equiv. of 
this functional group remained unaltered (final product 6e) 
when using Method B for the removal process (see Table 1). 
However, when the aqueous-solvent procedure (Method C) is 
applied instead, a complex mixture of reaction products is 
obtained, being 6e and 7 minor products (see Table 1) as 
shown by the 
I
H NMR analysis of the said mixture (see ESI†). 
This result clearly shows the interest of Methods A or B for 
straightforwardly decomplexing F-BODIPYs having easily 
hydrolyzable functions. 
 Significantly, it was also possible to remove the BF2 group 
in electronically deactivated 5g (meso-aryl group as the only F-
BODIPY substituent), in the absence of metals and under soft 
reaction conditions (Method B; see Table 1). It must be noted 
that, up to date, this kind of F-BODIPYs could only be 
decomplexed by using the Ravinkanth method,
2e
 but not under 
soft (r.t.) Lewis-acid conditions.
2f 
Conclusions 
In summary, methanesulfonic acids are able to remove BF2 in 
F-BODIPYs under soft reaction conditions (r.t. or refluxing 
CH2Cl2), which constitutes a valuable alternative to obtain 
dipyrrins from F-BODIPYs. 
 The new procedure is efficient for both meso-alkyl and 
meso-aryl F-BODIPYs, and its main goals are: (1) possibility of 
undergoing BF2 removal in electron-poor F-BODIPYs under 
metal-free soft acid conditions, (2) compatibility with labile 
functional groups (e.g., easily hydrolyzable functionalities), and 
(3) possibility of synthesizing highly reactive dipyrrins. We are 
convinced that the herein reported new procedure to obtain 
dipyrrins from F-BODIPYs has a great potential for the future 
development of new porphyrinoids and ion binding systems 
through dipyrrins having reactive groups which can only be 
straightforwardly introduced by using a F-BODIPY intermediate 
(e.g., by regiocontrolled SNAr reactions in halo-F-BODIPYs). 
Experimental 
General methods 
Common solvents were dried and distilled by standard 
procedures. All starting materials and reagents were obtained 
commercially and used without further purifications. NMR 
spectra were recorded at 20 ºC and the residual solvent peaks 
N HN NH HN
N
B
N
FF
R1
R2 R2
R2 R2
R3 R3
N HN
R1
R2 R2
R2 R2
R3 R3
RSO3H
a) RSO3H
5a-g 6a-g
b) Hydrolysis
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were used as internal standards. High resolution mass 
spectrometry (HRMS) was performed using electrospray 
ionization. Fourier transform infrared (FTIR) spectra were 
recorded without solving the sample, by using the attenuated 
total reflection (ATR) technique. 
General synthetic procedures 
 Method A. Methanesulfonic acid (480 mg, 1.00 mmol) was 
added to the corresponding F-BODIPY (0.05 mmol) in CH2Cl2 (2 
mL). The resulting mixture was stirred at 40 ºC for 24 h. Then, 
the reaction mixture was allowed to cool to room temperature 
and them H2O was added (5 mL). The layers were separated 
and the aqueous layer was extracted with CH2Cl2 (2 × 5 mL). 
The combined organic layers were dried over anhydrous 
Na2SO4 and the solvent was removed under reduced pressure 
to obtain the corresponding pure dipyrrin, as pyrrolium 
methanesulfonate salt (the known chemical instability of the 
free dipyrrins usually makes necessary their isolation as acid 
salts
2a,b
). If further purification is necessary, it can be achieved 
by washing the salt with a proper solvent (e.g., cold pentane).  
 Method B. Analogous to Method A, but using TfOH (150 
mg, 1.00 mmol) instead of methanesulfonic acid, and 
conducting the reaction at room temperature. 
 Method C. Analogous to Method B, but using aqueous 
CH2Cl2/water (40:1 in volume) instead of CH2Cl2. 
 Method D. Analogous to Method B, but using water 
instead of CH2Cl2. 
 (2Z)-5-Chloro-2-[(5-chloro-1H-pyrrol-2-yl)(4-methylphen-
yl)methylene]-2H-pyrrolium trifluoromethanesulfonate (4). 
Prepared according to Method B. Bright orange solid. 20.8 mg 
(92%). M.p.: 194-199 ºC. 
1
H NMR (CDCl3, 300 MHz) δ 7.33 (d, J 
= 7.9 Hz, 2H), 7.25 (d, J = 7.9 Hz, 2H), 6.57 (d, J = 4.3 Hz, 2H), 
6.26 (d, J = 4.3 Hz, 2H), 2.44 (s, 3H, CH3), ppm. 
13
C NMR (CDCl3, 
75 MHz) δ 141.5, 139.6, 138.3, 132.5, 130.9, 130.2, 128.6, 
116.8, 21.4 (Me) ppm.
 19
F NMR (CDCl3, 282 MHz) δ -78.53 (s, 
3F) ppm. ATR-FTIRν 3233, 2924, 1578, 1443, 1424, 1366, 1343, 
1316, 1252. 1038 cm
-1
. HRMS (m/z): [M+H]
+
 calcd. for 
C16H13Cl2N2 330.0452 found 330.0444. 
 (2Z)-2-[1-(3,5-Dimethyl-1H-pyrrol-2-yl)ethylidene]-3,5-di-
methyl-2H-pyrrolium methanesulfonate (6a). Prepared 
according to Method A. Bright orange solid. 14.3 mg (92%). 
M.p.: 160-163 ºC. 
1
H NMR (CDCl3, 300 MHz) δ 11.62 (br s, 2H), 
6.18 (s, 2H), 2.77 (s, 3H), 2.76 (s, 3H), 2.47 (s, 6H), 2.13 (s, 6H) 
ppm. 
13
C NMR (CDCl3, 75 MHz) δ 151.2, 149.3, 141.3, 132.3, 
119.3, 39.5, 22.6, 14.4, 13.9 ppm. ATR-FTIRν  3186, 2925, 
1546, 1449, 1294, 1179, 1040, 973 cm
-1
. HRMS (m/z): [M+H]
+
 
calcd. for C14H19N2 215.1541 found 215.1533. 
 (2Z)-4-Ethyl-2-[1-(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)eth-
ylidene]-3,5-dimethyl-2H-pyrrolium methanesulfonate (6b). 
Prepared according to Method A. Bright red solid. 18.1 mg 
(99%). M.p.: 154-157 ºC. 
1
H NMR (CDCl3, 300 MHz) δ 11.87 (br 
s, 2H), 2.82 (s, 3H), 2.79 (s, 3H), 2.46 (s, 6H), 2.39 (q, J = 7.5 Hz, 
4H), 1.99 (s, 6H), 1.04 (t, J = 7.5 Hz, 6H) ppm. 
13
C NMR (CDCl3, 
75 MHz) δ 148.8, 146.9, 137.0, 132.0, 131.6, 39.7, 23.2, 17.5, 
14.4, 12.2, 11.7 ppm. ATR-FTIRν 3169, 2927, 1570, 1514, 1304, 
1226, 1178, 1062, 1041, 958 cm
-1
. HRMS (m/z): [M+H]
+
 calcd 
for C18H27N2 271.2169 found 271.2163. 
 (2Z)-4-Ethyl-2-[1-(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)eth-
ylidene]-3,5-dimethyl-2H-pyrrolium trifluoromethanenesulfo-
nate (6b’). Prepared according to Method B. Bright red solid. 
20.6 mg (98%). M.p.: 139-143 ºC. 
1
H NMR (CDCl3, 300 MHz) δ 
10.97 (br s, 2H), 2.75 (s, 3H), 2.48-2.37 (m, 10H), 2.03 (s, 6H), 
1.07 (m, 6H) ppm. 
13
C NMR (CDCl3, 75 MHz) δ 149.1, 146.2, 
137.6, 132.1, 131.8, 22.5, 17.5, 14.4, 12.1, 11.8 ppm.
 19
F NMR 
(CDCl3, 282 MHz) δ  -78.73 (s, 3F) ppm. ATR-FTIRν 3229, 2966, 
2928, 1569, 1514, 1290, 1224, 1161, 1031, 958 cm
-1
. HRMS 
(m/z): [M+H]
+
 calcd. for C18H27N2 271.2169 found 271.2158. 
 (2Z)-4-tert-Butyl-2-[1-(4-tert-butyl-3,5-dimethyl-1H-pyrr-
ol-2-yl)decylidene]-3,5-dimethyl-2H-pyrrolium methanesulfo-
nate (6c). Prepared according to Method A. Bright red solid. 
25.9 mg (97%). M.p.: 161-165 ºC. 
1
H NMR (CDCl3, 300 MHz) δ 
11.91 (br s, 2H), 3.28 (t. J = 7.1 Hz, 2H), 2.77 (s, 3H), 2.68 (s, 
6H), 2.09 (s, 6H), 1.40 (s, 18 H), 1.45-1.10 (m, 14H), 0.85 (t, J = 
7.2 Hz, 3H) ppm. 
13
C NMR (CDCl3, 75 MHz) δ 152.1, 148.7, 
136.9, 136.8, 132.2, 36.3, 33.3, 31.9, 31.6, 31.4, 29.7, 29.4, 
29.3, 29.2, 22.6, 17.0, 14.9, 14.1 ppm. ATR-FTIRν 3181, 2925, 
1557, 1464, 1291. 1172, 1042, 970 cm
-1
. HRMS-ESI (m/z): 
[M+H]
+
 calcd. for C30H51N2 439.4049 found 439.4037. 
 (2Z)-4-Butyl-2-[1-(4-butyl-3,5-dimethyl-1H-pyrrol-2-yl)eth-
ylidene]-3,5-dimethyl-2H-pyrrolium methanesulfonate (6d). 
Prepared according to Method A. Bright orange solid. 21.1 mg 
(ca. quantitative). M.p.: 159-162 ºC. 
1
H NMR (CDCl3, 300 MHz) 
δ 12.00 (br s, 2H), 2.84 (s, 3H), 2.80 (s, 3H), 2.47 (s, 6H), 2.36 (t, 
J = 7.3 Hz, 4H), 1.98 (s, 6H), 1.45-1.22 (m, 8H), 0.92 (t, J = 7.1 
Hz, 6H) ppm. 
13
C NMR (CDCl3, 75 MHz) δ 149.0, 146.9, 137.2, 
132.0, 130.2, 39.8, 32.1, 24.0, 23.5, 22.5, 13.9, 12.3, 11.9 ppm. 
ATR-FTIRν 3163, 2956, 2929, 1570, 1546, 1513, 1442, 1419, 
1307, 1177, 1041, 924cm
-1
. HRMS (m/z): [M+H]
+
 calcd. for 
C22H35N2 327.2795 found 327.2787. 
 (2E)-2-[2-(Acetyloxy)-1-(4-ethyl-3,5-dimethyl-1H-pyrrol-2-
yl)ethylidene]-4-ethyl-3,5-dimethyl-2H-pyrrolium trifluoro-
methanesulfonate (6e) and (2E)-4-ethyl-2-(1-(4-ethyl-3,5-
dimethyl-1H-pyrrol-2-yl)-2-hydroxyethylidene)-3,5-dimethyl-
2H-pyrrolium trifluoromethanesulfonate (7). Prepared 
according to Method B. 22.5 mg, mixture of 6e (44%) and 7 
(55%). 
1
H NMR (mixture, CDCl3, 300 MHz) δ 11.03 (br s, 2H), 
10.97 (br s, 2.4), 5.38 (s, 2H), 4.98 (s, 2.4H), 2.47 (s, 6H), 2.49-
2.39 (m, 8.8H), 2.37 (s, 7.2H), 2.07 (s, 3H), 2.04 (s, 6H), 2.02 (s, 
7.2H), 1.10 (t, J = 7.5 Hz, 6H), 1.08 (t, J = 7.5 Hz, 7.2H) ppm. 
13
C 
NMR (mixture, CDCl3, 75 MHz) δ 170.0, 151.6, 150.0, 145.8, 
139.1, 138.8, 133.8, 132.9, 130.5, 130.1, 120.2 (q, J = 319.0 
Hz), 62.5, 61.6, 20.7, 17.6, 17.5, 14.3, 14.2, 12.6, 12.2, 11.7, 
11.6 ppm. 
19
F NMR (CDCl3, 282 MHz) δ -78.69 (s, 3F) ppm. 
 (2E)-2-[Cyano(3,4,5-trimethyl-1H-pyrrol-2-yl)methylene]-
3,4,5-trimethyl-2H-pyrrolium trifluoromethanesulfonate (6f). 
Prepared according to Method B. Bright purple solid. 19.8 mg 
(98%). M.p.: 177-179 ºC. 
1
H NMR (CDCl3, 300 MHz) δ 11.10 (br 
s, 2H), 2.59 (s, 6H), 2.49 (s, 6H), 2.04 (s, 6H) ppm.
13
C NMR 
(CDCl3, 75 MHz) δ 158.0, 142.1, 129.2, 129.0, 120.1 (q, J = 319.4 
Hz), 114.5, 105.2, 13.4, 12.8, 9.2 ppm. 
19
F NMR (CDCl3, 282 
MHz) δ -78.67 (s, 3F) ppm. ATR-FTIRν 3210, 2925, 2197, 1613, 
1565, 1287, 1242, 1157, 1029, 940 cm
-1
. HRMS (m/z): [M+H]
+
 
calcd. for C16H28N3 254.1650 found 254.1642. 
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 (2Z)-2-[(Mesityl)(1H-pyrrol-2-yl)methylene]-2H-pyrrolium 
trifluoromethanesulfonate (6g). The title compound was 
prepared according to Method B. Bright green solid. 20.2 mg 
(98%). M.p.: 174-176 ºC. 
1
H NMR (CDCl3, 300 MHz) δ 12.22 (br 
s, 2H), 8.08 (s, 2H), 6.98 (s, 2H), 6.77 (m, 2H), 6.61 (m, 2H), 
2.38 (s, 3H), 2.03 (s, 6H) ppm. 
13
C NMR (CDCl3, 75 MHz) δ 
149.9, 144.7, 139.9, 136.7, 135.5, 132.4, 131.6, 128.4, 118.1, 
21.1, 19.7 ppm. 
19
F NMR (CDCl3, 282 MHz) δ  -78.47 (s, 3F) 
ppm. ATR-FTIRν 3194, 2927, 1565, 1449, 1331, 1284, 1250, 
1038 cm
-1
. HRMS (m/z): [M+H]
+
 calcd. for C18H19N2 263.1543 
found 263.1533. 
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